James P. Howard

ORCID: 0000-0002-9989-6331
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Acute Myocardial Infarction Research
  • Cardiac electrophysiology and arrhythmias
  • Blood Pressure and Hypertension Studies
  • Cardiac Valve Diseases and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Advanced X-ray and CT Imaging
  • ECG Monitoring and Analysis
  • Cardiovascular Function and Risk Factors
  • Infective Endocarditis Diagnosis and Management
  • Heart Rate Variability and Autonomic Control
  • Advanced MRI Techniques and Applications
  • Sodium Intake and Health
  • Hemodynamic Monitoring and Therapy
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiovascular Health and Disease Prevention
  • Aortic Disease and Treatment Approaches
  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Syncope and Autonomic Disorders
  • Pain Management and Treatment
  • Cardiac Structural Anomalies and Repair
  • Health Systems, Economic Evaluations, Quality of Life

Imperial College London
2016-2025

Hammersmith Hospital
2017-2025

Imperial College Healthcare NHS Trust
2017-2025

Lung Institute
2015-2025

St George’s University Hospitals NHS Foundation Trust
2024

St George's, University of London
2024

Radiance Technologies (United States)
2023

Baylor Jack and Jane Hamilton Heart and Vascular Hospital
2020-2023

University College London
2022

National Heart Lung and Blood Institute
2022

Background: Ischemic heart disease (IHD) has been considered the top cause of mortality globally. However, countries differ in their rates and there have changes over time. Methods Results: We analyzed data submitted to World Health Organization from 2005 2015 by individual countries. explored patterns relationships with age, sex, income calculated age-standardized for each country addition crude death rates. In 5 illustrative which provided detailed data, we trends IHD 3 noncommunicable...

10.1161/circoutcomes.118.005375 article EN cc-by Circulation Cardiovascular Quality and Outcomes 2019-06-01

His bundle pacing is a new method for delivering cardiac resynchronization therapy (CRT). The authors performed head-to-head, high-precision, acute crossover comparison between and conventional biventricular CRT, measuring effects on ventricular activation hemodynamic function. Patients with heart failure left branch block referred CRT were recruited. Using noninvasive epicardial electrocardiographic imaging, the identified patients in whom shortened time. In these patients, compared of...

10.1016/j.jacc.2018.09.073 article EN cc-by Journal of the American College of Cardiology 2018-12-01

Most people who begin statins abandon them, most commonly because of side effects.The purpose this study was to assess daily symptom scores on statin, placebo, and no treatment in participants had abandoned statins.Participants received 12 1-month medication bottles, 4 containing atorvastatin 20 mg, empty. We measured intensity for each using an app (scale 1-100). also the "nocebo" ratio: ratio symptoms induced by taking statin that placebo.A total 60 were randomized 49 completed 12-month...

10.1016/j.jacc.2021.07.022 article EN cc-by Journal of the American College of Cardiology 2021-09-01

Percutaneous coronary intervention (PCI) is frequently performed to reduce the symptoms of stable angina. Whether PCI relieves angina more than a placebo procedure in patients who are not receiving antianginal medication remains unknown. We conducted double-blind, randomized, placebo-controlled trial with Patients stopped all medications and underwent 2-week symptom assessment phase before randomization. were then randomly assigned 1:1 ratio undergo or followed for 12 weeks. The primary end...

10.1056/nejmoa2310610 article EN New England Journal of Medicine 2023-11-11

BackgroundThe coronary sinus reducer (CSR) is proposed to reduce angina in patients with stable artery disease by improving myocardial perfusion. We aimed measure its efficacy, compared placebo, on ischaemia reduction and symptom improvement.MethodsORBITA-COSMIC was a double-blind, randomised, placebo-controlled trial conducted at six UK hospitals. Patients aged 18 years or older angina, disease, ischaemia, no further options for treatment were eligible. All completed quantitative...

10.1016/s0140-6736(24)00256-3 article EN cc-by The Lancet 2024-04-01

Ischaemic heart disease (IHD) is the leading cause of death worldwide and its prevention a public health priority.We analysed IHD mortality data from World Health Organisation as February 2014 by country, age income. Age-standardised rates country were calculated. We constructed cartogram which an algorithmically transformed world map that conveys numbers deaths in form spatial area.Of countries provided data, Russia, United States America Ukraine contributed largest deaths. India China...

10.1016/j.ijcard.2014.04.096 article EN cc-by-nc-sa International Journal of Cardiology 2014-04-13
Michel Azizi Roland E. Schmieder Felix Mahfoud Michael A. Weber Joost Daemen and 95 more Melvin D. Lobo Andrew S.P. Sharp Michael J. Bloch Jan Basile Yale Wang Manish Saxena Philipp Lurz Florian Rader Jeremy Sayer Naomi D.L. Fisher David Fouassier Neil C. Barman Helen Reeve-Stoffer Candace K. McClure Ajay J. Kirtane Desmond Jay Nedaa Skeik Robert S. Schwartz Suhail Dohad Ronald G. Victor Kintur Sanghvi Josh Costello Courtney Walsh Josephine Abraham Theophilus Owan Anu Abraham Laura Mauri Piotr Sobieszczky Jonathan S. Williams Chanwit Roongsritong Thomas M. Todoran Eric R. Powers Emily Hodskins Pete Fong Cheryl L. Laffer James S. Gainer Mark Robbins John P. Reilly Michael Cash Jessie Goldman Sandeep Aggarwal Gary S. Ledley David His Scott D. Martin Edward L. Portnay David A. Calhoun Thomas McElderry William Maddox Suzanne Oparil Pei-Hsiu Huang Powell Jose Matheen Khuddus Suzanne Zentko James O’Meara Ilie Barb Joseph M. Garasic Doug Drachman Randy Zusman Kenneth Rosenfield Chandan Devireddy Janice P. Lea Bryan Wells Rick Stouffer Alan L. Hinderliter Eric Pauley Srinivasa Potluri Scott Biedermann Sripal Bangalore Stephen Williams David Zidar Mehdi H. Shishehbor Barry Effron Marco Costa Jai Radhakrishnan Anthony Mathur Ajay Jain Sudha Ganesh Iyer Nicholas Robinson Sadat Ali Edroos Terry Levy Amit Patel David Beckett Clare Bent Justin E. Davies Neil Chapman Matthew Shun Shin James P. Howard Anil Joseph Richard D’Souza Robert Gerber Mohamad Faris Andrew John Marshall Cristina Elorz Robert Höllriegel Karl Fengler

Background: The multicenter, international, randomized, blinded, sham-controlled RADIANCE-HTN SOLO trial (A Study of the ReCor Medical Paradise System in Clinical Hypertension) demonstrated a 6.3 mm Hg greater reduction daytime ambulatory systolic blood pressure (BP) at 2 months by endovascular ultrasound renal denervation (RDN) compared with sham procedure among patients not treated antihypertensive medications. We report 6-month results after addition recommended standardized stepped-care...

10.1161/circulationaha.119.040451 article EN Circulation 2019-03-17

In this study, a systematic analysis was conducted of phasic intracoronary pressure and flow velocity in patients with severe aortic stenosis (AS) coronary artery disease, undergoing transcatheter valve replacement (TAVR), to determine how AS affects: 1) flow; 2) hyperemic 3) the most common clinically used indices severity, instantaneous wave-free ratio fractional reserve. A significant proportion have concomitant disease. The effect on pressure, flow, established invasive clinical severity...

10.1016/j.jcin.2018.07.019 article EN cc-by КАРДИОЛОГИЯ УЗБЕКИСТАНА 2018-08-25

Background: There are no data on how fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) associated with the placebo-controlled efficacy of percutaneous coronary intervention (PCI) in stable single-vessel artery disease. Methods: We report association between prerandomization invasive physiology within ORBITA (Objective Randomised Blinded Investigation With Optimal Medical Therapy Angioplasty Stable Angina), a trial patients who have angina angiographically severe disease...

10.1161/circulationaha.118.033801 article EN Circulation 2018-05-22
Florentina Simader Christopher Rajkumar Michael Foley Fiyyaz Ahmed‐Jushuf Shayna Chotai and 90 more Nina Bual A. M. Khokhär Aisha Gohar Ioannis Lampadakis Sashiananthan Ganesananthan Rachel H. Pathimagaraj Alexandra N. Nowbar John R. Davies Tom R. Keeble Peter O’Kane Peter Haworth Helen Routledge Tushar Kotecha James C. Spratt Rupert Williams Sukhjinder Nijjer Sayan Sen Nick Curzen Manas Sinha James P. Howard Graham Cole Frank E. Harrell Dárrel P. Francis Matthew Shun‐Shin Rasha Al‐Lamee Christopher Rajkumar Michael J. Foley Fiyyaz Ahmed‐Jushuf Florentina Simader Sashiananthan Ganesananthan Danqi Wang Muhammad Mohsin Rachel Pathimagaraj Krzysztof Macierzanka Ricardo Petraco Ramzi Khamis Graham Cole James P. Howard Jamil Mayet Dárrel P. Francis Arif Kokhar Aisha Gohar Ioannis Lampadakis Henry Seligman Amit Kaura Sukhjinder Nijjer Sayan Sen Ramrakha Punit Raffi Kaprielian Iqbal Malik Masood Khan Amarjit Sethi Rodney A. Foale Thomas R. Keeble Kare Tang John R. Davies Reto Gamma Gerald J. Clesham Jason Dungu Alamgir Kabir Shah Mohd Nazri Peter O’Kane Jonathan Hinton Jehangir Din Alexandra N. Nowbar Tushar Kotecha Peter Haworth James C. Spratt Rupert Williams Claudia Cosgrove Pitt Lim Helen Routledge Lal Hussain Mughal Jasper Trevelyan Manas Sinha Nick Curzen James S. Wilkinson Rohit Sirohi Alison Calver John Rawlins Richard J. Jabbour Neil Ruparelia Joban Sehmi Tim Kinnaird Fairoz Abdul Vasileios Panoulas David Collier George F. Thornton Sohaib Afzal Rasha Al‐Lamee

10.1016/j.jacc.2024.04.016 article EN Journal of the American College of Cardiology 2024-05-15
Coming Soon ...